Floatz logo

Memantine Hydrochloride

Chronic Subdural Hematoma

University of New MexicoEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Chronic Subdural Hematoma cohort.

Asset / SponsorPhaseRating
Tranexamic Acid
St. Olavs Hospital
Phase 3BB
Topamax
Université de Sherbrooke
Phase 4BB
Keppra
Université de Sherbrooke
Phase 4BB
Acetylsalicylic Acid
Tao Liu
Phase 4BB
Lipitor
Huashan Hospital
Phase 3BB

View all 18 →

Same molecule, other indications

Memantine Hydrochloride is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
67 / 100
View asset →
frontotemporal dementiaDormant
B
Indicative ·
62 / 100
View asset →
metastatic malignant neoplasm in the brainDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →